Loss of DLX3 tumor suppressive function promotes progression of SCC through EGFR–ERBB2 pathway
- 4 May 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 40 (21), 3680-3694
- https://doi.org/10.1038/s41388-021-01802-9
Abstract
Cutaneous squamous cell carcinoma (cSCC) ranks second in the frequency of all skin cancers. The balance between keratinocyte proliferation and differentiation is disrupted in the pathological development of cSCC. DLX3 is a homeobox transcription factor which plays pivotal roles in embryonic development and epidermal homeostasis. To investigate the impact of DLX3 expression on cSCC prognosis, we carried out clinicopathologic analysis of DLX3 expression which showed statistical correlation between tumors of higher pathologic grade and levels of DLX3 protein expression. Further, Kaplan–Meier survival curve analysis demonstrated that low DLX3 expression correlated with poor patient survival. To model the function of Dlx3 in skin tumorigenesis, a two-stage dimethylbenzanthracene (DMBA)/12-O-tetradecanoylphorbol 13-acetate (TPA) study was performed on mice genetically depleted of Dlx3 in skin epithelium (Dlx3cKO). Dlx3cKO mice developed significantly more tumors, with more rapid tumorigenesis compared to control mice. In Dlx3cKO mice treated only with DMBA, tumors developed after ~16 weeks suggesting that loss of Dlx3 has a tumor promoting effect. Whole transcriptome analysis of tumor and skin tissue from our mouse model revealed spontaneous activation of the EGFR–ERBB2 pathway in the absence of Dlx3. Together, our findings from human and mouse model system support a tumor suppressive function for DLX3 in skin and underscore the efficacy of therapeutic approaches that target EGFR–ERBB2 pathway.This publication has 45 references indexed in Scilit:
- Mouse Models of the Skin: Models to Define Mechanisms of Skin CarcinogenesisJournal of Skin Cancer, 2013
- Epidermal ablation of Dlx3 is linked to IL-17–associated skin inflammationProceedings of the National Academy of Sciences of the United States of America, 2011
- Dual Inhibition of Both the Epidermal Growth Factor Receptor and erbB2 Effectively Inhibits the Promotion of Skin Tumors during Two-Stage CarcinogenesisCancer Prevention Research, 2010
- HOXA9 regulates BRCA1 expression to modulate human breast tumor phenotypeJCI Insight, 2010
- Roles for Growth Factors in Cancer ProgressionPhysiology, 2010
- Multi-stage chemical carcinogenesis in mouse skin: Fundamentals and applicationsNature Protocols, 2009
- HOX transcription factors are potential therapeutic targets in non-small-cell lung cancer (targeting HOX genes in lung cancer)British Journal of Cancer, 2009
- Inducible Cutaneous Inflammation Reveals a Protumorigenic Role for Keratinocyte CXCR2 in Skin CarcinogenesisCancer Research, 2008
- Dlx3 is a crucial regulator of hair follicle differentiation and cyclingDevelopment, 2008
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001